These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22961830)

  • 21. Fatal hepatic failure and valproate.
    Bauer MS
    Am J Psychiatry; 2005 Jan; 162(1):192. PubMed ID: 15625224
    [No Abstract]   [Full Text] [Related]  

  • 22. [The dangers of valproate in women].
    Isojärvi J
    Duodecim; 1998; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 24. [Post-radiotherapy eruption in a patient treated with valproic acid. Rowell's syndrome?].
    Estève E; Favre A; Martin L
    Ann Dermatol Venereol; 2002; 129(6-7):901-3. PubMed ID: 12218921
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemostatic disorders caused by chronic use of valproic acid in neurosurgical patients. Thromboelastographic monitoring].
    Israelian LA; Lubnin AIu; Tseĭtlin AM; Stepanenko AIu; Kazarian AA; Golovteev AL; Melikian AG
    Anesteziol Reanimatol; 2010; (4):50-4. PubMed ID: 20922848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spasmodic dysphonia induced by valproic acid.
    Oh J; Park KD; Cho HJ; Choi KG; Jung SM
    Epilepsia; 2004 Jul; 45(7):880-1. PubMed ID: 15230719
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment with valproate and hepatic steatosis].
    Ortiz-Sáenz de Santa María R; Santiago-Fernández C; Cano-Del Pozo M; Pérez-Gil O; Soto-Alvarez MI; Barriuso-Pérez E; Moche-Loeri JA
    Rev Neurol; 2005 Dec 16-31; 41(12):766-7. PubMed ID: 16355364
    [No Abstract]   [Full Text] [Related]  

  • 28. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 29. Handling seizure data: special problems.
    Pierce MW; Shu VS
    Epilepsy Res Suppl; 1993; 10():175-8. PubMed ID: 8251093
    [No Abstract]   [Full Text] [Related]  

  • 30. [Paroxysmal tonic upward gaze deviation triggered by valproic acid within the context of focal epilepsy].
    Cantarin-Extremera V; Gutierrez-Solana LG; Duat-Rodriguez A; Lopez-Marin L; Ruiz-Falco ML; Leon-Gonzalez M; Perez-Villena A
    Rev Neurol; 2011 Sep; 53(5):318-9. PubMed ID: 21796611
    [No Abstract]   [Full Text] [Related]  

  • 31. [Valproic acid toxicity due to misinterpretation of plasma levels: increase in unbound fraction caused by hypoalbuminaemia and renal dysfunction].
    Ruiter-Visser R; Dols A; Smulders YM; Jacobs GE; Nauta KJ
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The contribution of magnetic resonance imaging to the diagnosis of type I glutaric aciduria].
    González-Granado LI
    Rev Neurol; 2009 Jan 1-15; 48(1):56. PubMed ID: 19145572
    [No Abstract]   [Full Text] [Related]  

  • 34. Valproic Acid related metabolic syndrome in patients with epilepsy.
    Mania M; Kasradze S; Okujava N
    Georgian Med News; 2011 May; (194):43-7. PubMed ID: 21685521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute Intermittent porphyria and valproic acid].
    Noval Menéndez J; Campoamor MT; Laborda B; López-Colina G
    Rev Clin Esp; 2012 Apr; 212(4):217-8. PubMed ID: 22112281
    [No Abstract]   [Full Text] [Related]  

  • 37. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 38. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
    de Maat MM; van Leeuwen HJ; Edelbroek PM
    Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy.
    Diluvio L; Campione E; Mordenti C; Bagnolo V; Cerminara C; Chimenti S; Bianchi L
    J Drugs Dermatol; 2013 Jan; 12(1):18-9. PubMed ID: 23377323
    [No Abstract]   [Full Text] [Related]  

  • 40. Can prolonged administration of valproic acid put patients with epilepsy at higher risk for development of Alzheimer's disease?
    Borhani Haghighi A; Sabayan B
    Epilepsy Behav; 2008 Jan; 12(1):206-7. PubMed ID: 17980672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.